ACF-2016-Annualreport with Donors V2.Indd
Total Page：16
File Type：pdf, Size：1020Kb
APRIL 1, 2015 – MARCH 31, 2016 THANKS TO YOU, WE WERE ABLE TO GO FURTHER FOR ALBERTANS THAN EVER BEFORE. ANNUAL 2016 REPORT 2016 - ANNUAL REPORT APRIL 1, 2015 – MARCH 31, 2016 Thank you for making life better for Albertans facing cancer, wherever they live. “The clinical trials, the patient navigators, the research, the fi nancial assistance. We just couldn’t do any of it, without you. MYKA OSINCHUK, ANGELA BOEHM, ” Chief Executive Offi cer Chair, Alberta Cancer Foundation We are pleased to share this year’s annual report with you, themed “unexpected places.” From the Lethbridge skyline to the canola fi elds in Barrhead—we stand alongside every Albertan who hears the words, “you have cancer.” We work hard to deliver that promise with our partners in Alberta Health Services, who provide excellent care and treatment in all corners, and some of the most unexpected places, in Alberta. Throughout this report, we highlight the breadth and depth of support that you, our donors, and our partners from across the province provide—bringing to life the words: “We will help.” 02 03 2016 - ANNUAL REPORT APRIL 1, 2015 – MARCH 31, 2016 Thank you for investing in the brightest minds and compassionate care teams “across our great province. It helps us make groundbreaking discoveries, and provide truly innovative clinical care. NANCY GUEBERT, DR. MATT PARLIAMENT, Chief Program Offi cer, Interim Senior Medical Director, CancerControl Alberta CancerControl Alberta Your support allows our teams to accelerate research discoveries, translate them to our patients faster, and to create patient-centred care in all 17 cancer centres in this province. From the fi rst symptom to survivorship, our goal is to deliver expert care and support for patients and families across the province, no matter where they live. In short, you are helping ensure the best possible treatment outcome for patients and their loved ones. 04 05 2016 - ANNUAL REPORT APRIL 1, 2015 – MARCH 31, 2016 Every year, the Alberta Cancer Foundation invests more than $20 million across this province. developed a prototype and is currently testing the internal Immunotherapy $5.4 Million Our investments are focused on making a direct impact for patients. Some are more personal—such as providing blanket warmers, hardware. With this development, head and neck patients will Immunotherapy is a way of using a person’s own immune or helping patients transition back into their community after treatment—while others are more transformative. We make life better be able to regain their quality of life, no matter where they system to fight cancer. This treatment has been shown to for Albertans facing cancer by reducing the cancer risk, diagnosing it earlier, treating it more eectively, and improving the quality of live in Alberta. be highly eective; however, severe side eects due to poor life for patients and their families. accuracy are preventing widespread usage. Through the use Patient Financial Assistance Program Here is a sample of some of those larger investments you, our donors, have been supporting. of small molecule drug development, the Alberta Cancer $1 Million last year Foundation partnered with the Li Ka Shing Institute to invest in The Alberta Cancer Foundation provides financial support the development of a new orally available immunotherapy that to patients in need undergoing active treatment. This provides a more accurate, lower-side-eect, option to patients. REDUCE CANCER RISK TREAT CANCER MORE EFFECTIVELY program covers costs such as housing, food, childcare and transportation. In 2015, this program was accessed nearly Tomorrow Project $5.3 Million Colorectal Cancer $2.9 Million IMPROVE QUALITY OF LIFE 8,722 times (up from 3,000 in 2014), and the need continues The Tomorrow Project is a long-term study investigating Colorectal cancer patients are often treated with some form to grow. why some people get cancer and others do not. It has of chemotherapy, radiation or both. The eectiveness of Alberta Cancer Foundation Patient Navigator now expanded across Canada, and includes more than these treatments can be diminished by the ability of cancer Program $6.8 Million Screening for Distress $2.5 Million 300,000 participants. The Foundation helped recruit 50,000 cells to repair the damage these treatments introduce. Patient Navigators can be found at 15 regional and This psychosocial program helps care teams identify Albertans to provide biological samples that scientists will The Alberta Cancer Foundation is investing in drugs that community cancer centres across Alberta. They help guide psychological and physical issues that can arise during now analyze and study. prevent these repair systems, and sensitize cancer cells patients through the health system and access community cancer treatment. This program has been implemented as to chemotherapy and radiation. By blocking this repair, support when needed. This program is fully funded by a standard of care in all cancer care facilities across the DETECT CANCER EARLIER chemotherapy and radiation therapy will be more eective. our donors, and is estimated to save the health system at province. Alberta is one of the first provinces in the country least $1 million by alleviating visits to family physicians and to achieve 90 per cent screening rates. YOUR INVESTMENTS YOUR INVESTMENTS YOUR Lung Cancer Screening $2.5 Million Clinical Trials $10 Million emergency rooms for non-emergent issues. This program was accessed nearly 15,784 times in 2015/2016. Thanks to a transformational investment from the Alberta Clinical trials are the engine that drives life-saving Healing Arts $300,000 Cancer Foundation, a pilot project will screen 800 high-risk treatment. By investing in leading-edge clinical trials This provincial program is completely funded by Alberta patients over three years in Calgary, Edmonton and Fort research, the Alberta Cancer Foundation is bringing results Head and Neck: Portable Swallowing Cancer Foundation donors and helps patients and families McMurray. Currently, a lung cancer diagnosis often comes to Alberta’s cancer patients years before they are available Therapy Unit $1.9 Million find creative expression to confront the many complex too late, when doctors can do little to treat it. Lung cancer to the general public. Over the past five years, more than For many head and neck patients, cancer treatment can feelings that come with a diagnosis of cancer. Programs survival today is a dismal 17 per cent due to late-stage 6,000 Albertans have taken part in 500 trials. This not only diminish their ability to swallow, having a dramatic impact available include art therapy, expressive and spontaneous detection. The goal is to launch a province-wide screening provides patient access to the newest treatments, it also on their quality of life. Current therapy is only available at painting, hand drumming, laughter yoga, origami making and program, catching cancer early when curative treatment is alleviates the financial burden on the health system. For clinics, which means much travel and time away from home other creative outlets. still an option. This project has already confirmed several every patient that participates in a trial, pharmaceutical and is required. The Alberta Cancer Foundation is investing in a lung cancer diagnoses—both detected at an early stage that private companies cover the related health costs of the trial. portable device, called Mobili-T, that provides biofeedback led to successful surgeries. In 2015, it is estimated that Alberta Health Services realized to the patient about how well they are swallowing and what an $8 million savings in prescription drug costs because of to work on, in real time. The research team has already clinical trials. 06 07 2016 - ANNUAL REPORT APRIL 1, 2015 – MARCH 31, 2016 Thank you for allowing Albertans to receive the care they need, closer to home—from “radiation, to physical therapy, to fi nancial assistance—all are critical parts of the cancer journey.” TREVOR CAMPBELL, Radiation Manager, Jack Ady Cancer Centre Last year, 450,000 Albertans received treatment in their local cancer centres. Thanks to you, we off er support to patients, no matter where they receive treatment, and we’re able to improve the patient experience, from blanket warmers, to comfortable chemo chairs, to staff education. Every step of the way, there you are. 08 09 2016 - ANNUAL REPORT APRIL 1, 2015 – MARCH 31, 2016 2016 Fundraising & Net Investment Income Breakdown 2016 Statement of Revenue, Expenses & Fund Balances (in $ millions) Revenue From Fundraising & Net Investment Income For the year ended March 31, 2016 2016 2015 2014 Fundraising & Investments Income $12.4 Total Fundraising & Net Investment Income $37,305 $43,867 $39,388 Net Fundraising Fundraising Costs $10,562 $11,917 $10,610 Individual Special Investment Philanthropy Events and Net Net Fundraising & Investments $26,743 $31,950 $28,778 Income Investment Income Fundraising Costs % of Revenue 28% 27% 27% $14.9 $10 $37.3 Administration & Operating Expenses Operating Expenses $ 2,976 $ 2,750 $ 2,709 Awareness & Public Engagement $ 1,221 $ 1,291 $ 1,388 Investment In Programs Administrative Costs % of Revenue 8% 6% 7% Public Engagement Costs % of Revenue 3% 3% 3% % Net Fundraising to Cause 60% 64% 63% $16.4 FINANCIAL SUMMARY Other Revenues FINANCIAL SUMMARY Total Enhanced Research* Investment in Lotteries, Net $ 1,157 $ ,666 $ ,929 Care Programs Grants Received/Returned Grants $ 1,542 $ 1,676 $ 1,331 $4.8 $21.2 Net Revenue Before Use of Funds $25,245 $30,252 $26,941 Investment in Programs Endowment Building & Research $16,383 $15,176 $16,774 Enhanced Care, Prevention & Screening $ 4,766 $ 4,959 $ 4,837 *Including research programs that directly benefit Albertans’ lives by detecting cancer earlier, reducing risk, as well as building research endowments. TOTAL FUNDS INVESTED $21,150 $20,134 $21,611 10 11 2016 - ANNUAL REPORT APRIL 1, 2015 – MARCH 31, 2016 Thank you for enabling us to discover new ways to detect, diagnose, treat and reduce “cancer risks, by investing in clinical trials—they help loved ones today, and answer questions for generations to come.” DR.